Pannecouque; Christophe

Patent Applications and Registrations

Patent applications and USPTO patent grants for Pannecouque; Christophe.The latest application filed is for "antiviral activity of novel bicyclic heterocycles".

Company Profile

0.10.12

Pannecouque; Christophe - Leuven N/A BE
Pannecouque; Christophe - Heverlee BE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antiviral activity of novel bicyclic heterocycles Grant 9,730,944 - De Jonghe , et al. August 15, 2	2017-08-15
Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production Grant 9,522,932 - Herdewijn , et al. December 20, 2	2016-12-20
Antiviral Activity of Novel Bicyclic Heterocycles App 20160030447 - De Jonghe; Steven ; et al.	2016-02-04
Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production Grant 9,249,177 - Herdewijn , et al. February 2, 2	2016-02-02
Phosphonate Nucleosides Useful As Active Ingredients In Pharmaceutical Compositions For The Treatment Of Viral Infections, And Intermediates For Their Production App 20160009750 - HERDEWIJN; Piet ; et al.	2016-01-14
Antiviral activity of bicyclic heterocycles Grant 9,193,741 - De Jonghe , et al. November 24, 2	2015-11-24
Phosphonate Nucleosides Useful As Active Ingredients In Pharmaceutical Compositions For The Treatment Of Viral Infections, And Intermediates For Their Production App 20140316127 - HERDEWIJN; Piet ; et al.	2014-10-23
Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production Grant 8,809,520 - Herdewijn , et al. August 19, 2	2014-08-19
Phosphonate Nucleosides Useful As Active Ingredients In Pharmaceutical Compositions For The Treatment Of Viral Infections, And Intermediates For Their Production App 20140039179 - HERDEWIJN; Piet ; et al.	2014-02-06
Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production Grant 8,501,709 - Herdewijn , et al. August 6, 2	2013-08-06
Antiviral Activity of Novel Bicyclic Heterocycles App 20130190297 - De Jonghe; Steven ; et al.	2013-07-25
Use Of N-aminoimidazole Cytoprotective Compounds For Treating Cell Death And/or Gsk-3 Mediated Diseases App 20120283303 - Pannecouque; Christophe ; et al.	2012-11-08
Phosphonate Nucleosides Useful As Active Ingredients In Pharmaceutical Compositions For The Treatment Of Viral Infections, And Intermediates For Their Production App 20120108531 - Herdewijn; Piet ; et al.	2012-05-03
Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production Grant 8,076,310 - Herdewijn , et al. December 13, 2	2011-12-13
Use Of N-aminoimidazole Cytoprotective Compounds For Treating Cell Death And/or Gsk-3 Mediated Diseases App 20090149523 - Pannecouque; Christophe ; et al.	2009-06-11
Phosponate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production App 20070185062 - Herdewijn; Piet ; et al.	2007-08-09
Pharmaceutical compositions and method for the treatment of retroviral infections App 20030187003 - De Clercq, Erik ; et al.	2003-10-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.